S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors

LESSONS LEARNED: Despite having significant rationale, S0502 failed to accrue for a number of reasons. Vetting a trial first, with scientific experts and funding agencies, does not guarantee success, especially when dealing with a rare tumor and/or one with an existing highly effective therapy. In t...

Full description

Saved in:
Bibliographic Details
Published in:Oncologist
Main Authors: Blanke, Charles D., Rankin, Cathy, Corless, Christopher, Eary, Janet F., Mulder, Karen, Okuno, Scott H., George, Suzanne, Heinrich, Michael
Format: Artigo
Language:Inglês
Published: AlphaMed Press 2015
Subjects:
Clinical Trial Results
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4679092/
https://ncbi.nlm.nih.gov/pubmed/26576593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0295
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items